- cafead   Sep 16, 2022 at 10:52: AM
via A committee of the European Medicines Agency (EMA) recommended converting the conditional marketing authorizations (CMA) of Pfizer (NYSEFE) and BioNTech's (NASDAQ:BNTX) Comirnaty and Moderna's (NASDAQ:MRNA) Spikevax COVID-19 vaccines into standard marketing authorizations.
article source
article source